A new, improved DBS technique that targets specific subpopulations of neurons in the globus pallidus with short bursts of stimulation shows promising results as a treatment for Parkinson's disease.
Drugs that increase signaling of Sonic Hedgehog (Shh) can help suppress the involuntary movements associated with dopamine replacement therapy for those with Parkinson's disease.
Study suggests seven compensation strategies to help those with Parkinson's disease improve mobility and walking problems.
A new small-scale study reveals transcranial direct current stimulation improved gait and increased the benefits of aerobic exercise in Parkinson's patients.
A new hydrogel that acts as a gateway to transfer stem cells into the brain and facilitate repair to damaged tissue may effectively treat neurological conditions like Parkinson's disease and stroke.
Researchers highlight some of the current strategies being pursued to help restore lost function and regenerate brain areas affected by Parkinson's disease.
Two new intranasal drugs slow inflammation and stop the spread of alpha-synuclein in mouse models of Parkinson's disease. The drug also improved gait and balance in the animals. If the results are able to be replicated in humans, researchers say the drugs could be hailed as a "remarkable advance" in the treatment of Parkinson's disease.
Study reports a significant number of people with Parkinson's disease have precise deficits when learning from instructions. Researchers say the problems are associated with differences in brain function.
An experimental small molecule helped restore the removal of mitochondria from dopamine-producing neurons in the brain. The findings may help in the development of new therapies for Parkinson's disease.
Farnesol, a naturally occurring compound found in berries and other fruits, prevents the loss of dopamine-producing neurons and reverses Parkinson's associated damage to the brain in mouse models.
Weekly musical dance classes can help to improve daily living and motor functions in those with mild-to-moderate Parkinson's disease.